Leu72Met Polymorphism in Ghrelin Gene: A Potential Risk Factor for Hypertension in Type 2 Diabetes Patients

Monika Buraczynska, Jakub Golacki, Wojciech Zaluska Department of Nephrology, Medical University of Lublin, Lublin, PolandCorrespondence: Monika Buraczynska, Department of Nephrology, Medical University of Lublin, Jaczewskiego 8, Lublin, 20-950, Poland, Tel +48 81 7244716, Fax +48 81 7244357, Email...

Full description

Bibliographic Details
Main Authors: Buraczynska M, Golacki J, Zaluska W
Format: Article
Language:English
Published: Dove Medical Press 2023-03-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
Online Access:https://www.dovepress.com/leu72met-polymorphism-in-ghrelin-gene-a-potential-risk-factor-for-hype-peer-reviewed-fulltext-article-DMSO
_version_ 1811161174077603840
author Buraczynska M
Golacki J
Zaluska W
author_facet Buraczynska M
Golacki J
Zaluska W
author_sort Buraczynska M
collection DOAJ
description Monika Buraczynska, Jakub Golacki, Wojciech Zaluska Department of Nephrology, Medical University of Lublin, Lublin, PolandCorrespondence: Monika Buraczynska, Department of Nephrology, Medical University of Lublin, Jaczewskiego 8, Lublin, 20-950, Poland, Tel +48 81 7244716, Fax +48 81 7244357, Email monika.buraczynska@umlub.plObjective: Ghrelin (GHRL) is known to be engaged in metabolic and cardiovascular processes. There is evidence suggesting its involvement in the regulation of blood pressure and hypertension. The purpose of this preliminary case–control study was to determine the involvement of the Leu72Met (rs696217) polymorphism in the GHRL gene in type 2 diabetes (T2DM).Methods: The Leu72Met polymorphism was genotyped in 820 individuals with T2DM and 400 healthy subjects by the PCR-RFLP technique. The polymorphism distribution was first compared in those withT2DM and controls, then in subgroups of participants representing different clinical phenotypes.Results: No significant association was identified between Leu72Met and T2DM. The distribution of polymorphism was analyzed in subgroups of individuals with different clinical phenotypes (hypertension, diabetic nephropathy, obesity). In this analysis, rs696217 was associated with hypertension. The presence of T allele was associated with higher risk of hypertension (OR = 2.50, 95% CI 1.68– 3.73, p < 0.001). When adjusted for age, gender and BMI, the association was still significant (OR = 2.62, 95% CI 1.83– 3.96, p < 0.001). A post hoc power calculations based on a minor allele frequency revealed the power of 97% for comparison between HY+ and HY- subgroups.Conclusion: This is the first study demonstrating that the ghrelin Leu72Met SNP is associated with hypertension in Caucasians with T2DM. If confirmed in larger studies in different populations, it may be a novel potential risk factor for hypertension in individuals withT2DM.Keywords: ghrelin gene, type 2 diabetes, hypertension, Leu72Met polymorphism, risk allele
first_indexed 2024-04-10T06:11:15Z
format Article
id doaj.art-f0942e8db648405b907a2bf3d49a17f6
institution Directory Open Access Journal
issn 1178-7007
language English
last_indexed 2024-04-10T06:11:15Z
publishDate 2023-03-01
publisher Dove Medical Press
record_format Article
series Diabetes, Metabolic Syndrome and Obesity
spelling doaj.art-f0942e8db648405b907a2bf3d49a17f62023-03-02T18:11:56ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity1178-70072023-03-01Volume 1655756481954Leu72Met Polymorphism in Ghrelin Gene: A Potential Risk Factor for Hypertension in Type 2 Diabetes PatientsBuraczynska MGolacki JZaluska WMonika Buraczynska, Jakub Golacki, Wojciech Zaluska Department of Nephrology, Medical University of Lublin, Lublin, PolandCorrespondence: Monika Buraczynska, Department of Nephrology, Medical University of Lublin, Jaczewskiego 8, Lublin, 20-950, Poland, Tel +48 81 7244716, Fax +48 81 7244357, Email monika.buraczynska@umlub.plObjective: Ghrelin (GHRL) is known to be engaged in metabolic and cardiovascular processes. There is evidence suggesting its involvement in the regulation of blood pressure and hypertension. The purpose of this preliminary case–control study was to determine the involvement of the Leu72Met (rs696217) polymorphism in the GHRL gene in type 2 diabetes (T2DM).Methods: The Leu72Met polymorphism was genotyped in 820 individuals with T2DM and 400 healthy subjects by the PCR-RFLP technique. The polymorphism distribution was first compared in those withT2DM and controls, then in subgroups of participants representing different clinical phenotypes.Results: No significant association was identified between Leu72Met and T2DM. The distribution of polymorphism was analyzed in subgroups of individuals with different clinical phenotypes (hypertension, diabetic nephropathy, obesity). In this analysis, rs696217 was associated with hypertension. The presence of T allele was associated with higher risk of hypertension (OR = 2.50, 95% CI 1.68– 3.73, p < 0.001). When adjusted for age, gender and BMI, the association was still significant (OR = 2.62, 95% CI 1.83– 3.96, p < 0.001). A post hoc power calculations based on a minor allele frequency revealed the power of 97% for comparison between HY+ and HY- subgroups.Conclusion: This is the first study demonstrating that the ghrelin Leu72Met SNP is associated with hypertension in Caucasians with T2DM. If confirmed in larger studies in different populations, it may be a novel potential risk factor for hypertension in individuals withT2DM.Keywords: ghrelin gene, type 2 diabetes, hypertension, Leu72Met polymorphism, risk allelehttps://www.dovepress.com/leu72met-polymorphism-in-ghrelin-gene-a-potential-risk-factor-for-hype-peer-reviewed-fulltext-article-DMSOghrelin genetype 2 diabeteshypertensionleu72met polymorphismrisk allele
spellingShingle Buraczynska M
Golacki J
Zaluska W
Leu72Met Polymorphism in Ghrelin Gene: A Potential Risk Factor for Hypertension in Type 2 Diabetes Patients
Diabetes, Metabolic Syndrome and Obesity
ghrelin gene
type 2 diabetes
hypertension
leu72met polymorphism
risk allele
title Leu72Met Polymorphism in Ghrelin Gene: A Potential Risk Factor for Hypertension in Type 2 Diabetes Patients
title_full Leu72Met Polymorphism in Ghrelin Gene: A Potential Risk Factor for Hypertension in Type 2 Diabetes Patients
title_fullStr Leu72Met Polymorphism in Ghrelin Gene: A Potential Risk Factor for Hypertension in Type 2 Diabetes Patients
title_full_unstemmed Leu72Met Polymorphism in Ghrelin Gene: A Potential Risk Factor for Hypertension in Type 2 Diabetes Patients
title_short Leu72Met Polymorphism in Ghrelin Gene: A Potential Risk Factor for Hypertension in Type 2 Diabetes Patients
title_sort leu72met polymorphism in ghrelin gene a potential risk factor for hypertension in type 2 diabetes patients
topic ghrelin gene
type 2 diabetes
hypertension
leu72met polymorphism
risk allele
url https://www.dovepress.com/leu72met-polymorphism-in-ghrelin-gene-a-potential-risk-factor-for-hype-peer-reviewed-fulltext-article-DMSO
work_keys_str_mv AT buraczynskam leu72metpolymorphisminghrelingeneapotentialriskfactorforhypertensionintype2diabetespatients
AT golackij leu72metpolymorphisminghrelingeneapotentialriskfactorforhypertensionintype2diabetespatients
AT zaluskaw leu72metpolymorphisminghrelingeneapotentialriskfactorforhypertensionintype2diabetespatients